Advertisement
Screener

ProPhase Labs, Inc. (PRPH) Pre-Tax Income

2.8 / 5 stars · 68/120 Roast Me

ProPhase Labs, Inc. Pre-Tax Income

ProPhase Labs, Inc. (PRPH) reported Pre-Tax Income of -$3.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.

Financial Statements › Income Statement

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-19

  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$3.04M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$3.80M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$8.02M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$7.00M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$23.39M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$42.33M.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$22.40M, a 197.77% decline from fiscal 2022.
  • ProPhase Labs, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was $22.91M, a 331.82% increase from fiscal 2021.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filedIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filedIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filedIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed
2026-06-30-$3.04M
10-Q · filed 2026-08-19
-$6.84M
10-Q · filed 2026-08-19
-$14.86M
derived: sum of 3 quarters · filed 2026-08-19
-$21.86M
derived: sum of 4 quarters · filed 2026-08-19
2026-03-31-$3.80M
10-Q/A · filed 2026-07-09
-$3.98M
10-Q · filed 2026-06-30
-$11.82M
derived: sum of 2 quarters · filed 2026-07-09
-$18.82M
derived: sum of 3 quarters · filed 2026-07-09
-$22.51M
derived: sum of 4 quarters · filed 2026-08-19
2025-12-31-$8.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01
-$15.02M
derived: sum of 2 quarters · filed 2026-06-01
-$18.71M
derived: sum of 3 quarters · filed 2026-08-19
-$23.39M
10-K · filed 2026-06-01
2025-09-30-$7.00M
10-Q · filed 2025-11-19
-$10.69M
derived: sum of 2 quarters · filed 2026-08-19
-$15.37M
10-Q · filed 2025-11-19
-$34.38M
derived: sum of 4 quarters · filed 2026-08-19
2025-06-30-$3.69M
10-Q · filed 2026-08-19
-$8.37M
10-Q · filed 2026-08-19
-$27.39M
derived: sum of 3 quarters · filed 2026-08-19
-$34.86M
derived: sum of 4 quarters · filed 2026-08-19
2025-03-31-$4.68M
10-Q/A · filed 2026-07-09
-$23.70M
derived: sum of 2 quarters · filed 2026-07-09
-$31.17M
derived: sum of 3 quarters · filed 2026-07-09
-$38.92M
derived: sum of 4 quarters · filed 2026-07-09
2024-12-31-$19.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01
-$26.49M
derived: sum of 2 quarters · filed 2026-06-01
-$34.24M
derived: sum of 3 quarters · filed 2026-06-01
-$42.33M
10-K · filed 2026-06-01
2024-09-30-$7.47M
10-Q · filed 2025-11-19
-$9.10M
10-Q · filed 2024-11-13
-$15.22M
derived: sum of 2 quarters · filed 2025-11-19
-$23.31M
10-Q · filed 2025-11-19
-$26.37M
10-Q · filed 2024-11-13
-$34.58M
derived: sum of 4 quarters · filed 2025-11-19
2024-06-30-$7.75M
10-Q · filed 2025-08-13
-$8.44M
10-Q · filed 2024-08-14
-$15.84M
10-Q · filed 2025-08-13
-$17.27M
10-Q · filed 2024-08-14
-$27.10M
derived: sum of 3 quarters · filed 2025-08-13
-$33.89M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$8.09M
10-Q · filed 2025-05-20
-$8.83M
10-Q · filed 2024-05-10
-$19.35M
derived: sum of 2 quarters · filed 2025-05-20
-$26.14M
derived: sum of 3 quarters · filed 2025-05-20
-$31.05M
derived: sum of 4 quarters · filed 2025-05-20
2023-12-31-$11.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01
-$18.05M
derived: sum of 2 quarters · filed 2025-04-01
-$22.96M
derived: sum of 3 quarters · filed 2025-04-01
-$22.40M
10-K · filed 2025-04-01
-$22.80M
10-K · filed 2024-03-29
2023-09-30-$6.79M
10-Q · filed 2024-11-13
-$11.70M
derived: sum of 2 quarters · filed 2024-11-13
-$11.13M
10-Q · filed 2024-11-13
-$16.32M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$4.91M
10-Q · filed 2024-08-14
-$4.35M
10-Q · filed 2024-08-14
-$9.54M
derived: sum of 3 quarters · filed 2024-08-14
-$7.76M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$564.00K
10-Q · filed 2024-05-10
-$4.63M
derived: sum of 2 quarters · filed 2024-05-10
-$2.85M
derived: sum of 3 quarters · filed 2024-05-10
$7.56M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$5.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$3.41M
derived: sum of 2 quarters · filed 2024-03-29
$7.00M
derived: sum of 3 quarters · filed 2024-03-29
$22.91M
10-K · filed 2024-03-29
2022-09-30$1.78M
10-Q · filed 2023-11-13
$12.19M
derived: sum of 2 quarters · filed 2023-11-13
$28.10M
10-Q · filed 2023-11-13
$37.72M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$10.41M
10-Q · filed 2023-08-11
$26.32M
10-Q · filed 2023-08-11
$35.94M
derived: sum of 3 quarters · filed 2023-08-11
$31.96M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$15.91M
10-Q · filed 2023-05-12
$25.53M
derived: sum of 2 quarters · filed 2023-05-12
$21.55M
derived: sum of 3 quarters · filed 2023-05-12
$20.16M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$9.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$5.64M
derived: sum of 2 quarters · filed 2023-03-29
$4.25M
derived: sum of 3 quarters · filed 2023-03-29
$5.30M
10-K · filed 2023-03-29
2021-09-30-$3.98M
10-Q · filed 2022-11-10
-$5.37M
derived: sum of 2 quarters · filed 2022-11-10
-$4.32M
10-Q · filed 2022-11-10
2021-06-30-$1.40M
10-Q · filed 2022-08-12
-$338.00K
10-Q · filed 2022-08-12
2021-03-31$1.06M
10-Q · filed 2022-05-13
2020-12-31-$2.31M
10-K · filed 2022-03-31
2019-12-31-$3.11M
10-K · filed 2020-03-26
2018-12-31-$354.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
-$1.25M
derived: sum of 2 quarters · filed 2020-03-26
-$1.51M
derived: sum of 3 quarters · filed 2020-03-26
-$1.47M
10-K · filed 2020-03-26
2018-09-30-$897.00K
10-Q · filed 2018-11-14
-$1.16M
derived: sum of 2 quarters · filed 2018-11-14
-$1.11M
10-Q · filed 2018-11-14
-$1.34M
derived: sum of 4 quarters · filed 2019-03-26
2018-06-30-$260.00K
10-Q · filed 2018-08-20
-$216.00K
10-Q · filed 2018-08-20
-$444.00K
derived: sum of 3 quarters · filed 2019-03-26
-$1.22M
derived: sum of 4 quarters · filed 2019-03-26
2018-03-31$43.00K
10-Q/A · filed 2018-08-20
-$184.00K
derived: sum of 2 quarters · filed 2019-03-26
-$961.00K
derived: sum of 3 quarters · filed 2019-03-26
-$2.42M
derived: sum of 4 quarters · filed 2019-03-26
2017-12-31-$227.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
-$1.00M
derived: sum of 2 quarters · filed 2019-03-26
-$2.46M
derived: sum of 3 quarters · filed 2019-03-26
-$3.66M
10-K · filed 2019-03-26
2017-09-30-$777.00K
10-Q · filed 2018-11-14
-$2.24M
derived: sum of 2 quarters · filed 2018-11-14
-$3.44M
10-Q · filed 2018-11-14
-$5.14M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$1.46M
10-Q · filed 2018-08-20
-$2.66M
10-Q · filed 2018-08-20
-$4.37M
derived: sum of 3 quarters · filed 2018-08-20
-$4.20M
derived: sum of 4 quarters · filed 2018-08-20
2017-03-31-$1.20M
10-Q/A · filed 2018-08-20
-$2.91M
derived: sum of 2 quarters · filed 2018-08-20
-$2.74M
derived: sum of 3 quarters · filed 2018-08-20
-$3.87M
derived: sum of 4 quarters · filed 2018-08-20
2016-12-31-$1.71M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20
-$1.54M
derived: sum of 2 quarters · filed 2018-08-20
-$2.67M
derived: sum of 3 quarters · filed 2018-08-20
-$4.01M
10-K/A · filed 2018-08-20
-$2.87M
10-K · filed 2017-02-24
2016-09-30$167.00K
10-Q · filed 2016-11-14
-$960.00K
derived: sum of 2 quarters · filed 2016-11-14
-$2.30M
10-Q · filed 2016-11-14
-$2.05M
derived: sum of 4 quarters · filed 2018-08-20
2016-06-30-$1.13M
10-Q · filed 2016-08-11
-$2.46M
10-Q · filed 2016-08-11
-$2.21M
derived: sum of 3 quarters · filed 2018-08-20
-$1.61M
derived: sum of 4 quarters · filed 2018-08-20
2016-03-31-$1.34M
10-Q · filed 2016-05-13
-$1.09M
derived: sum of 2 quarters · filed 2018-08-20
-$484.00K
derived: sum of 3 quarters · filed 2018-08-20
-$2.05M
derived: sum of 4 quarters · filed 2018-08-20
2015-12-31$250.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20
$852.00K
derived: sum of 2 quarters · filed 2018-08-20
-$714.00K
derived: sum of 3 quarters · filed 2018-08-20
-$2.09M
10-K/A · filed 2018-08-20
-$3.60M
10-K · filed 2016-03-29
2015-09-30$602.00K
10-Q · filed 2016-11-14
-$964.00K
derived: sum of 2 quarters · filed 2016-11-14
-$2.34M
10-Q · filed 2016-11-14
-$3.02M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30-$1.57M
10-Q · filed 2016-08-11
-$2.95M
10-Q · filed 2016-08-11
-$3.62M
derived: sum of 3 quarters · filed 2017-02-24
-$6.84M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31-$1.38M
10-Q · filed 2016-05-13
-$2.06M
derived: sum of 2 quarters · filed 2017-02-24
-$5.27M
derived: sum of 3 quarters · filed 2017-02-24
-$8.41M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31-$676.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
-$3.89M
derived: sum of 2 quarters · filed 2017-02-24
-$7.03M
derived: sum of 3 quarters · filed 2017-02-24
-$7.83M
10-K · filed 2017-02-24
2014-09-30-$3.22M
10-Q · filed 2015-11-13
-$6.35M
derived: sum of 2 quarters · filed 2015-11-13
-$7.16M
10-Q · filed 2015-11-13
-$6.56M
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30-$3.14M
10-Q · filed 2015-08-12
-$3.94M
10-Q · filed 2015-08-12
-$3.34M
derived: sum of 3 quarters · filed 2016-03-29
-$2.11M
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31-$804.00K
10-Q · filed 2015-05-13
-$206.00K
derived: sum of 2 quarters · filed 2016-03-29
$1.03M
derived: sum of 3 quarters · filed 2016-03-29
-$689.00K
derived: sum of 4 quarters · filed 2016-03-29
2013-12-31$598.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$1.83M
derived: sum of 2 quarters · filed 2016-03-29
$115.00K
derived: sum of 3 quarters · filed 2016-03-29
$405.00K
10-K · filed 2016-03-29
2013-09-30$1.24M
10-Q · filed 2014-11-13
-$483.00K
derived: sum of 2 quarters · filed 2014-11-13
-$193.00K
10-Q · filed 2014-11-13
$259.00K
derived: sum of 4 quarters · filed 2015-03-27
2013-06-30-$1.72M
10-Q · filed 2014-08-12
-$1.43M
10-Q · filed 2014-08-12
-$977.00K
derived: sum of 3 quarters · filed 2015-03-27
$97.00K
derived: sum of 4 quarters · filed 2015-03-27
2013-03-31$290.00K
10-Q · filed 2014-05-12
$742.00K
derived: sum of 2 quarters · filed 2015-03-27
$1.82M
derived: sum of 3 quarters · filed 2015-03-27
-$114.00K
derived: sum of 4 quarters · filed 2015-03-27
2012-12-31$452.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27
$1.53M
derived: sum of 2 quarters · filed 2015-03-27
-$404.00K
derived: sum of 3 quarters · filed 2015-03-27
-$1.09M
10-K · filed 2015-03-27
2012-09-30$1.07M
10-Q · filed 2013-11-13
-$856.00K
derived: sum of 2 quarters · filed 2013-11-13
-$1.54M
10-Q · filed 2013-11-13
-$3.38M
derived: sum of 4 quarters · filed 2014-03-27
2012-06-30-$1.93M
10-Q · filed 2013-08-13
-$2.62M
10-Q · filed 2013-08-13
-$4.45M
derived: sum of 3 quarters · filed 2014-03-27
-$3.34M
derived: sum of 4 quarters · filed 2014-03-27
2012-03-31-$688.00K
10-Q · filed 2013-05-10
-$2.52M
derived: sum of 2 quarters · filed 2014-03-27
-$1.41M
derived: sum of 3 quarters · filed 2014-03-27
-$2.38M
derived: sum of 4 quarters · filed 2014-03-27
2011-12-31-$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
-$723.00K
derived: sum of 2 quarters · filed 2014-03-27
-$1.70M
derived: sum of 3 quarters · filed 2014-03-27
-$2.71M
10-K · filed 2014-03-27
2011-09-30$1.11M
10-Q · filed 2012-11-14
$136.00K
derived: sum of 2 quarters · filed 2012-11-14
-$877.00K
10-Q · filed 2012-11-14
-$2.05M
derived: sum of 4 quarters · filed 2013-03-28
2011-06-30-$974.00K
10-Q · filed 2012-08-13
-$1.99M
10-Q · filed 2012-08-13
-$3.16M
derived: sum of 3 quarters · filed 2013-03-28
-$2.21M
derived: sum of 4 quarters · filed 2013-03-28
2011-03-31-$1.01M
10-Q · filed 2012-05-11
-$2.18M
derived: sum of 2 quarters · filed 2013-03-28
-$1.24M
derived: sum of 3 quarters · filed 2013-03-28
2010-12-31-$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
-$224.00K
derived: sum of 2 quarters · filed 2013-03-28
-$3.54M
10-K · filed 2013-03-28
2010-09-30$947.00K
10-Q · filed 2011-11-14
-$2.37M
10-Q · filed 2011-11-14
2009-12-31-$3.93M
10-K · filed 2012-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Pulmatrix, Inc. (PULM)United States$0.006B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26